Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694746 · ClinicalTrials.gov registry record · Phase 1
Study of Fish Oil to Reduce ALT Levels in Adolescents
A Phase 1 study, sponsored by Boston University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00694746 is a Phase 1 study that was terminated before completion, run by Boston University. The registered enrollment target is 3 participants.
The verdict
NCT00694746, a Phase 1 study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
This trial will provide preliminary data to test the hypothesis that a six-month treatment period with fish oil for overweight adolescent with mild to moderate persistent elevation of ALT levels and presence of hepatic steatosis on CT-scan is safe and will result in decreased ALT.
Interventions
- DRUG Placebo
- DRUG Omega-3-acid ethyl esters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00694746
The ClinicalTrials.gov registry entry for NCT00694746 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00694746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00694746 about?
NCT00694746 is a clinical study titled "Study of Fish Oil to Reduce ALT Levels in Adolescents". This trial will provide preliminary data to test the hypothesis that a six-month treatment period with fish oil for overweight adolescent with mild to moderate persistent elevation of ALT levels and presence of hepatic steatosis on CT-scan is safe and will result in decreased ALT.
What is the current status of trial NCT00694746?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-06. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00694746?
The interventions under investigation include: Placebo (DRUG), Omega-3-acid ethyl esters (DRUG).
Who is sponsoring clinical trial NCT00694746?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.